(S)-2-(3-((R)-2-carboxy-2-(4-iodobenzamido)ethyl)ureido)pentanedioic Acid

ID: ALA4461865

PubChem CID: 152021787

Max Phase: Preclinical

Molecular Formula: C16H18IN3O8

Molecular Weight: 507.24

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CC[C@H](NC(=O)NC[C@@H](NC(=O)c1ccc(I)cc1)C(=O)O)C(=O)O

Standard InChI:  InChI=1S/C16H18IN3O8/c17-9-3-1-8(2-4-9)13(23)19-11(15(26)27)7-18-16(28)20-10(14(24)25)5-6-12(21)22/h1-4,10-11H,5-7H2,(H,19,23)(H,21,22)(H,24,25)(H,26,27)(H2,18,20,28)/t10-,11+/m0/s1

Standard InChI Key:  UKWMEQZENRUSPF-WDEREUQCSA-N

Molfile:  

 
     RDKit          2D

 28 28  0  0  0  0  0  0  0  0999 V2000
   32.3779  -14.5732    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0856  -14.1646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7933  -14.5732    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.5010  -14.1646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2087  -14.5732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9164  -14.1646    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.2087  -15.3904    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.0856  -13.3475    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.5010  -13.3475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2087  -12.9389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2087  -12.1217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9164  -11.7131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.5010  -11.7131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.6702  -14.1646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9625  -14.5732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2548  -14.1646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2548  -13.3475    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.5471  -14.5732    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.9625  -15.3904    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2548  -15.7990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2548  -16.6162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5471  -15.3904    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.5437  -17.0211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5433  -17.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2516  -18.2469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9616  -17.8339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9585  -17.0189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2526  -19.0641    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  2  8  2  0
  4  9  1  1
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
  1 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 15 19  1  1
 19 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 21  1  0
 25 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4461865

    ---

Associated Targets(Human)

FOLH1 Tclin Glutamate carboxypeptidase II (711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 507.24Molecular Weight (Monoisotopic): 507.0139AlogP: 0.09#Rotatable Bonds: 10
Polar Surface Area: 182.13Molecular Species: ACIDHBA: 5HBD: 6
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.73CX Basic pKa: CX LogP: 0.27CX LogD: -9.72
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.24Np Likeness Score: -0.65

References

1. Kim K, Kwon H, Barinka C, Motlova L, Nam S, Choi D, Ha H, Nam H, Son SH, Minn I, Pomper MG, Yang X, Kutil Z, Byun Y..  (2020)  Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen.,  63  (6): [PMID:32097010] [10.1021/acs.jmedchem.9b02022]

Source